ArticleCancer immunology, immunotherapy : CII2023

Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence.

Qin-Qin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.